Cargando…
Teicoplanin inhibits Ebola pseudovirus infection in cell culture
There is currently no approved antiviral therapy for treatment of Ebola virus disease. To discover readily available approved drugs that can be rapidly repurposed for treatment of Ebola virus infections, we screened 1280 FDA-approved drugs and identified glycopeptide antibiotic teicoplanin inhibitin...
Autores principales: | Wang, Yizhuo, Cui, Rui, Li, Guiming, Gao, Qianqian, Yuan, Shilin, Altmeyer, Ralf, Zou, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113690/ https://www.ncbi.nlm.nih.gov/pubmed/26585243 http://dx.doi.org/10.1016/j.antiviral.2015.11.003 |
Ejemplares similares
-
Tolcapone Potently Inhibits Seminal Amyloid Fibrils Formation and Blocks Entry of Ebola Pseudoviruses
por: Qiu, Mengjie, et al.
Publicado: (2020) -
Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
por: Wu, Canhao, et al.
Publicado: (2022) -
Effects of teicoplanin on cell number of cultured cell lines
por: Kashkolinejad-Koohi, Tahere, et al.
Publicado: (2015) -
IgY antibodies against Ebola virus possess post-exposure protection in a murine pseudovirus challenge model and excellent thermostability
por: Zhang, Yuan, et al.
Publicado: (2021) -
Flow Virometry Quantification of Host Proteins on the Surface of HIV-1 Pseudovirus Particles
por: Burnie, Jonathan, et al.
Publicado: (2020)